para-Methoxyphenylpiperazine

Para-Methoxyphenylpiperazine
Clinical data
Other names	pMeOPP; pMPP; p-MeOPP; p-MPP; 4-MeOPP; 4-MPP; MeOPP; MPP; Paraperazine
Routes of; administration	Oral
ATC code	none;
Legal status
Legal status	DE: NpSG (Industrial and scientific use only); NZ: Class C;
Pharmacokinetic data
Metabolism	The human liver P450 CYP2D6 converts para-methoxyphenylpiperazine by demethylation to para-hydroxyphenylpiperazine.
Excretion	Renal
Identifiers
	IUPAC name 1-(4-methoxyphenyl)piperazine;
CAS Number	38212-30-5 ;
PubChem CID	269722;
ChemSpider	237180 ;
UNII	P385M92GYG;
CompTox Dashboard (EPA)	DTXSID30191591 ;
ECHA InfoCard	100.048.918
Chemical and physical data
Formula	C11H16N2O
Molar mass	192.262 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1=CC(=CC=C1N2CCNCC2)OC;
	InChI InChI=1S/C11H16N2O/c1-14-11-4-2-10(3-5-11)13-8-6-12-7-9-13/h2-5,12H,6-9H2,1H3 ; Key:MRDGZSKYFPGAKP-UHFFFAOYSA-N ;
	(what is this?) (verify)

para-Methoxyphenylpiperazine (pMeOPP), also known as 4-methoxyphenylpiperazine (4-MeOPP), is a substituted piperazine derivative with stimulant effects which has been sold as an ingredient in "Party pills", initially in New Zealand and subsequently in other countries around the world.^[1]

^ Elliott S (2011). "Current awareness of piperazines: pharmacology and toxicology". Drug Test Anal. 3 (7–8): 430–438. doi:10.1002/dta.307. PMID 21744514.

[Elliott2011-1] Elliott S (2011). "Current awareness of piperazines: pharmacology and toxicology". Drug Test Anal. 3 (7–8): 430–438. doi:10.1002/dta.307. PMID 21744514.

[1]